CD4 and COVID-19: Conversely, the significantly higher CD4+ T cell responses at 4 weeks after the second booster in the non-COVID-19 group suggested that vaccine-induced T cell immunity may play a role in protection against SARS-CoV-2 infection and progression to severe disease.